Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market
Eli Lilly shares rose 4% on Monday, driven by compelling new data for its next-generation obesity drug, retatrutide, with analysts and investors expecting it to extend the
June 08, 2026
Republican Steve Hilton advances to general election in race for California governor
Big 12 commish and ADs meet, discuss Texas Tech QB Sorsby's NCAA eligibility restored by court
Qantas, low-cost arm Jetstar to launch services from new Western Sydney Airport
Catalonia's famed human tower climbers greet Pope Leo in Barcelona
China's Xi says he reached important consensus with Kim in North Korea visit, KCNA reports
GM to offer EV owners ability to sell power to US electricity grid
Bengals restructure Joe Burrow's contract to free up cap space, AP source says